London, UK – April 24, 2017. Raremark will deliver a presentation titled Informed consent: Moving from lawyer-friendly to patient-friendly at the Clinical Trials Innovation Summit, which takes place today in Boston, Massachusetts. 2016 was a record year for the number of applications made to the FDA for orphan designation, so the need for a more tailored, […]
London, UK – February 6, 2017. Raremark will today deliver a presentation titled Patient-Powered Research in Rare Disease at Patients as Partners Europe 2017, a conference taking place in London, UK from February 6-7, 2017. The presentation will explain how Raremark has been engaging members of its online communities, generating data that may be helpful […]
London, UK – January 19, 2017. Realizing the full potential of big data in rare disease will require integration with intelligence from datasets that are small, as discussed in a Raremark white paper published today. Big data has become a buzzword in healthcare, with benefits ranging from the prediction of patient responses to drugs and […]
London, UK – November 7, 2016. Raremark founder, Julie Walters, has been named one of BioBeat’s 50 Movers and Shakers in BioBusiness 2016, in recognition of her pioneering work in rare disease. BioBeat’s annual report celebrates 50 of the most extraordinary women pushing the boundaries in life science and health. Julie said: “It’s an honour […]
London, UK – October 17, 2016. Raremark today joined Go to Grow, the London Mayor’s International Business Program for high-growth companies in the UK capital with plans to expand internationally. Raremark will be one of around 50 companies in the latest cohort of the program, which will also include Doctor Care Anywhere, Deontics, Babylon, Baby2Body […]
Raremark will deliver a presentation titled “Patient-centric clinical trials in rare disease” at the Bio2business Biotech Outsourcing Strategies 2016 conference, which takes place in London, UK.